CVS Health Corporation [NYSE: CVS] gained 0.12% on the last trading session, reaching $104.29 price per share at the time. The company report on December 22, 2021 that CVS Health to Present at the 40th Annual J.P. Morgan Healthcare Conference.
CVS Health (NYSE: CVS) today announced that President and CEO Karen S. Lynch and Executive Vice President and Chief Financial Officer Shawn Guertin will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at approximately 8:15 am ET.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
About CVS HealthCVS Health is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and approximately 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. Wherever and whenever people need us, we help them with their health – whether that’s managing chronic diseases, staying compliant with their medications, or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system – and their personal health care – by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Learn more at www.cvshealth.com.
CVS Health Corporation represents 1.32 billion in outstanding shares, while the company has a total market value of $138.36 billion with the latest information. CVS stock price has been found in the range of $103.80 to $105.44.
If compared to the average trading volume of 5.55M shares, CVS reached a trading volume of 6044843 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about CVS Health Corporation [CVS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVS shares is $110.73 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVS stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for CVS Health Corporation shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 14, 2021. While these analysts kept the previous recommendation, Seaport Research Partners raised their target price to Buy. The new note on the price target was released on December 01, 2021, representing the official price target for CVS Health Corporation stock. Previously, the target price had yet another raise to $89, while Wells Fargo analysts kept a Equal Weight rating on CVS stock.
The Average True Range (ATR) for CVS Health Corporation is set at 1.66, with the Price to Sales ratio for CVS stock in the period of the last 12 months amounting to 0.49. The Price to Book ratio for the last quarter was 1.85, with the Price to Cash per share for the same quarter was set at 9.68. Price to Free Cash Flow for CVS in the course of the last twelve months was 11.00 with Quick ratio for the last quarter at 0.70.
Trading performance analysis for CVS stock
CVS Health Corporation [CVS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.48. With this latest performance, CVS shares gained by 14.77% in over the last four-week period, additionally plugging by 28.21% over the last 6 months – not to mention a rise of 48.01% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVS stock in for the last two-week period is set at 76.43, with the RSI for the last a single of trading hit 80.66, and the three-weeks RSI is set at 72.90 for CVS Health Corporation [CVS]. The present Moving Average for the last 50 days of trading for this stock 95.35, while it was recorded at 103.80 for the last single week of trading, and 85.83 for the last 200 days.
CVS Health Corporation [CVS]: A deeper dive into fundamental analysis
CVS Health Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 0.90.
CVS Health Corporation [CVS]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CVS Health Corporation go to 5.71%.
An analysis of insider ownership at CVS Health Corporation [CVS]
There are presently around $104,913 million, or 78.90% of CVS stock, in the hands of institutional investors. The top three institutional holders of CVS stocks are: VANGUARD GROUP INC with ownership of 108,357,306, which is approximately 0.801% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 94,594,948 shares of the stock with an approximate value of $9.85 billion in CVS stocks shares; and STATE STREET CORP, currently with $5.75 billion in CVS stock with ownership of nearly 1.311% of the company’s market capitalization.
1,047 institutional holders increased their position in CVS Health Corporation [NYSE:CVS] by around 40,257,397 shares. Additionally, 823 investors decreased positions by around 38,574,731 shares, while 276 investors held positions by with 928,398,241 shares. The mentioned changes placed institutional holdings at 1,007,230,369 shares, according to the latest SEC report filing. CVS stock had 116 new institutional investments in for a total of 3,919,557 shares, while 85 institutional investors sold positions of 4,543,430 shares during the same period.